Nuchal translucency in pregnancies conceived after assisted reproduction technology

Ultrasound in Obstetrics and Gynecology

Volumn 25, Issue 3, 2005, Pages 234-238

  Hui, P W ^a   Tang, M H Y ^a   Lam, Y H ^b   Yeung, W S B ^b   Ng, E H Y ^b   Ho, P C ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Embryo transfer; Frozen embryo transfer; in vitro fertilization; Intracytoplasmic sperm injection; Nuchal translucency

Indexed keywords

ARTICLE; CRYOPRESERVATION; DOWN SYNDROME; EMBRYO TRANSFER; FERTILIZATION IN VITRO; FETUS; FETUS ECHOGRAPHY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; PREGNANCY COMPLICATION; PRIORITY JOURNAL;

EID: 15944412529     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1002/uog.1846     Document Type: Article

References (43)

1. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-869.
2. Pandya PP, Goldberg H, Walton B, Riddle A, Shelley S, Snijders RJ, Nicolaides KH. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units. Ultrasound Obstet Gynecol 1995; 5: 20-25.
3. Braithwaite JM, Morris RW, Economides DL. Nuchal translucency measurements: frequency distribution and changes with gestation in a general population. Br J Obstet Gynaecol 1996; 103: 1201-1204.
4. Whitlow BJ, Chatzipapas IK, Economides DL. The effect of fetal neck position on nuchal translucency measurement. Br J Obstet Gynaecol 1998; 105: 872-876.
5. Schaefer M, Laurichesse-Delmas H, Ville Y. The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks. Ultrasound Obstet Gynecol 1998; 11: 271-273.
6. Herman A, Maymon R, Dreazen E, Caspi E, Bukovsky I, Weinraub Z. Image magnification does not contribute to the repeatability of caliper placement in measuring nuchal translucency thickness. Ultrasound Obstet Gynecol 1998; 11: 266-270.
7. Edwards A, Mulvey S, Wallace EM. The effect of image size on nuchal translucency measurement. Prenat Diagn 2003; 23: 284-286.
8. Thilaganathan B, Khare M, Williams B, Wathen NC. Influence of ethnic origin on nuchal translucency screening for Down's syndrome. Ultrasound Obstet Gynecol 1998; 12: 112-114.
9. Spencer K, Ong CY, Liao AW, Nicolaides KH. The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities. Prenat Diagn 2000; 20: 491-494.
10. Chen M, Lam YH, Tang MH, Lee CP, Sin SY, Tang R, Wong HS, Wong SF. The effect of ethnic origin on nuchal translucency at 10-14 weeks of gestation. Prenat Diagn 2002; 22: 576-578.
11. Spencer K, Ong CY, Liao AW, Papademetriou D, Nicolaides KH. The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum-free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 2000; 20: 673-675.
12. Lam YH, Tang MH, Lee CP, Sin SY, Tang R, Wong HS, Wong SF. The effect of fetal gender on nuchal translucency at 10-14 weeks of gestation. Prenat Diagn 2001; 21: 627-629.
13. Larsen SO, Wojdemann KR, Shalmi AC, Sundberg K, Christiansen M, Tabor A. Gender impact on first trimester markers in Down syndrome screening. Prenat Diagn 2002; 22: 1207-1208.
14. Spencer K, Ong CY, Liao AW, Nicolaides KH. The influence of parity and gravidity on first trimester markers of chromosomal abnormality. Prenat Diagn 2000; 20: 792-794.
15. Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H. Down's syndrome screening marker levels following assisted reproduction. Prenat Diagn 1996; 16: 1111-1114.
16. Heinonen S, Ryynanen M, Kirkinen P, Hippelainen M, Saarikoski S. Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril 1996; 66: 398-403.
17. Ribbert LS, Kornman LH, De Wolf BT, Simons AH, Jansen CA, Beekhuis JR, Mantingh A. Maternal serum screening for fetal Down syndrome in IVF pregnancies. Prenat Diagn 1996; 16: 35-38.
18. Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller DN Jr. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 1997; 90: 98-101.
19. Lam YH, Yeung WS, Tang MH, Ng EH, So WW, Ho PC. Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilization. Hum Reprod 1999; 14: 2120-2123.
20. Hui PW, Tang MH, Lam YH, Ng EH, Yeung WS, Ho PC. Maternal serum hCG and alpha-fetoprotein levels in pregnancies conceived after IVF or ICSI with fresh and frozen-thawed embryos. Hum Reprod 2003; 18: 572-575.
21. Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001; 16: 1501-1504.
22. Wojdemann KR, Larsen SO, Shalmi A, Sundberg K, Christiansen M, Tabor A. First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat Diagn 2001; 21: 563-565.
23. Maymon R, Shulman A. Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally-conceived singletons. Hum Reprod 2002; 17: 1081-1085.
24. Yu Ng EH, Yeung WS, Yee Lan Lau E, So WW, Ho PC. High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles. Hum Reprod 2000; 15: 250-255.
25. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998; 352: 343-346.
26. Lam YH, Lee CP, Sin SY, Tang R, Wong HS, Wong SF, Fong DY, Tang MH, Woo HH. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome. Prenat Diagn 2002; 22: 730-735.
27. Orlandi F, Rossi C, Allegra A, Krantz D, Hallahan T, Orlandi E, Macri J. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 2002; 22: 718-721.
28. Lai TH, Chen SC, Tsai MS, Lee FK, Wei CF. First-trimester screening for Down syndrome in singleton pregnancies achieved by intrauterine insemination. J Assist Reprod Genet 2003; 20: 327-331.
29. Roberts LJ, Bewley S, Mackinson AM, Rodeck CH. First trimester fetal nuchal translucency: problems with screening the general population. 1. Br J Obstet Gynaecol 1995; 102: 381-385.
30. Scott F, Boogert A, Sinosich M, Anderson J. Establishment and application of a normal range for nuchal translucency across the first trimester. Prenat Diagn 1996; 16: 629-634.
31. von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse. Anat Embryol (Berl) 1998; 197: 105-124.
32. Bohlandt S, von Kaisenberg CS, Wewetzer K, Christ B, Nicolaides KH, Brand-Saberi B. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses. Hum Reprod 2000; 15: 1155-1158.
33. von Kaisenberg CS, Nicolaides KH, Brand-Saberi B. Lymphatic vessel hypoplasia in fetuses with Turner syndrome. Hum Reprod 1999; 14: 823-826.
34. Haak MC, Bartelings MM, Jackson DG, Webb S, van Vugt JM, Gittenberger-de Groot AC. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod 2002; 17: 1086-1092.
35. Montenegro N, Matias A, Areias JC, Castedo S, Barros H. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997; 10: 265-268.
36. Haak MC, van Vugt JM. Pathophysiology of increased nuchal translucency: a review of the literature. Hum Reprod Update 2003; 9: 175-184.
37. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998; 11: 391-400.
38. Reynders CS, Pauker SP, Benacerraf BR. First trimester isolated fetal nuchal lucency: significance and outcome. J Ultrasound Med 1997; 16: 101-105.
39. Pajkrt E, Mol BW, Bleker OP, Bilardo CM. Pregnancy outcome and nuchal translucency measurements in fetuses with a normal karyotype. Prenat Diagn 1999; 19: 1104-1108.
40. Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001; 17: 102-105.
41. Tarlatzis BC, Grimbizis G. Pregnancy and child outcome after assisted reproduction techniques. Hum Reprod 1999; 14: 231-242.
42. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004; 103: 551-563.
43. Maymon R, Dreazen E, Rozinsky S, Bukovsky I, Weinraub Z, Herman A. Comparison of nuchal translucency measurement and mid-gestation serum screening in assisted reproduction versus naturally conceived singleton pregnancies. Prenat Diagn 1999; 19: 1007-1011.